Autori: Bila Jelena S
| Naslov | Managing novel therapies and concomitant medications in chronic lymphocytic leukemia: key challenges (Review) |
| Autori | Kozarac Sofija Ivanovic Jelena Mitrovic Marko Tomic-Vujovic Kristina Arsenovic Isidora Suvajdzic-Vukovic Nada D Bogdanovic Andrija D Vidovic Ana D Todorovic-Balint Milena R Bila Jelena S Mitrovic Mirjana M Lekovic Danijela R Djunic Irena S Virijevic Marijana Trivic Aleksandar S Micic Jelena D Antic Darko A |
| Info | FRONTIERS IN PHARMACOLOGY, (2025), vol. 15 br. , str. - |
| Projekat | Ministry of Science, Technological Development and Innovation [451-03-65/2024-03/200110] |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Phase 3 Study of Teclistamab (Tec) in Combination with Lenalidomide (Len) and Tec Alone Versus Len Alone in Newly Diagnosed Multiple Myeloma (NDMM) As Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT): Safety Run-in (SRI) Results from the Majestec-4/EMN30 Trial (Meeting Abstract) |
| Autori | Zamagni Elena ... Bila Jelena S ... (broj koautora 53) |
| Info | BLOOD, (2024), vol. 144 br. , Suppl. 1, str. 495-498 |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Risk Factors for Venous Thromboembolism in Acute Promyelocytic Leukemia (Article) |
| Autori | Sabljic Nikica Pantic Nikola M Virijevic Marijana Rajic Jovan Cvetkovic Mirjana Trajkovic Lazar Pravdic Zlatko Bukumiric Zoran M Suvajdzic-Vukovic Nada D Bogdanovic Andrija D Vidovic Ana D Todorovic-Balint Milena R Bila Jelena S Lekovic Danijela R Djunic Irena S Antic Darko A Mitrovic Mirjana M |
| Info | CANCERS, (2024), vol. 16 br. 24, str. - |
| Projekat | Ministry of Science, Technological Development and Innovation of the Republic of Serbia; [451-03-65/2004-03/200110] |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Does Double Mean Trouble? Coexistence of Myeloproliferative and Lymphoproliferative Neoplasms (Article) |
| Autori | Lekovic Danijela R Ivanovic Jelena Terzic Tatjana T Perunicic-Jovanovic Maja D Dencic-Fekete Marija Jovanovic Jelica V Arsenovic Isidora Vukovic Vojin M Bila Jelena S Bogdanovic Andrija D Antic Darko A |
| Info | JOURNAL OF CLINICAL MEDICINE, (2024), vol. 13 br. 6, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study (Article) |
| Autori | Pour Ludek ... Bila Jelena S ... (broj koautora 16) |
| Info | HAEMATOLOGICA, (2024), vol. 109 br. 3, str. 895-905 |
| Projekat | [NCT04649060] |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Bortezomib-Cyclophosphamide-Dexamethasone (VCD) Vs Bortezomib-LenalidomideDexamethasone (VRD) in Newly Diagnosed Multiple Myeloma: A Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG) (Meeting Abstract) |
| Autori | Kastritis Efstathios ... Bila Jelena S ... Cvetkovic Zorica P Markovic Olivera B ... Sretenovic Aleksandra M ... (broj koautora 20) |
| Info | BLOOD, (2023), vol. 142 br. , Suppl. 1, str. - |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3trial (Article) |
| Autori | Dimopoulos Meletios Athanasios ... Bila Jelena S ... (broj koautora 21) |
| Info | LANCET HAEMATOLOGY, (2023), vol. 10 br. 10, str. E813-E824 |
| Projekat | European Myeloma Network; Janssen Research Development |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Lighthouse: melflufen, daratumumab, and dexamethasone versus daratumumab in relapsed/refractory multiple myeloma refractory to an imid and a proteasome inhibitor or with ≥3 prior lines of therapy (Meeting Abstract) |
| Autori | Mateos Maria-Victoria Szarejko Monika Bila Jelena S Schjesvold Fredrik Spicka Ivan Maisnar Vladimir Jurczyszyn Artur Grudeva-Popova Zhanet Hajek Roman Usenko Hanna Thuresson Marcus Norin Stefan Jarefors Sara Richardson Paul Pour Ludek |
| Info | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, (2023), vol. 23 br. , Suppl. 2, str. S200-S201 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa |
| Naslov | The second revision of international staging system (R2-ISS) in newly diagnosed multiple myeloma patients: RWE settings (Meeting Abstract) |
| Autori | Sretenovic Aleksandra M Mitrovic Marko Vukosavljevic Nikola Kecman Natalija Jovanovic Jelica V Bukumiric Zoran M Bila Jelena S |
| Info | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, (2023), vol. 23 br. , Suppl. 2, str. S93-S93 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa |
| Naslov | MajesTEC-4: Phase 3 trial of Teclistamab plus Lenalidomide versus Lenalidomide in patients with newly diagnosed multiple myeloma (Meeting Abstract) |
| Autori | Cook Gordon ... Bila Jelena S ... (broj koautora 22) |
| Info | BRITISH JOURNAL OF HAEMATOLOGY, (2023), vol. 201 br. , Suppl. 1, str. 57-57 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa |
